Characteristics and outcomes of patients undergoing esophagogastroduodenoscopy in Gaza strip hospitals: a retrospective study Authors: Tayseer Afifi, Khamis Elessi, Mosheer Al-Dahdouh, Hasan Hamdan, Ahmed Eid, Khaled Siyam, Mustafa Abu Jayyab, Isam Awadallah Published: 2025 ABSTRACT BackgroundUpper gastrointestinal (GI) disorders represent a major cause of morbidity worldwide, and esophagogastroduodenoscopy (EGD) remains the gold standard for both diagnosis and therapeutic guidance. In resource-limited settings such as the Gaza Strip, the utilization of EGD provides critical insights into disease burden, patient characteristics, and clinical outcomes. This study aimed to evaluate the demographic characteristics, clinical indications, endoscopic findings, and management outcomes of patients undergoing EGD at the Gaza Strip Hospitals.MethodsA retrospective analytical study was conducted at the endoscopy unit of the Gaza Strip Hospitals, covering the period from 2017 to 2022. All patients who underwent EGD during this timeframe were included, while those with combined double-scope procedures, colonoscopy alone, or procedures performed before 2017 were excluded. Data were extracted from hospital records using a structured questionnaire developed based on recent literature. Variables included sociodemographic characteristics, presenting complaints, laboratory investigations, and endoscopic findings. Data were analyzed using SPSS version 23.ResultsA total of 1,159 patients were included, with a mean age of 42.6 ± 16.8 years (range 2–92 years), and a nearly equal sex distribution (50.6% male vs. 49.4% female). The majority of patients were admitted through the outpatient department (92.3%). The most frequent presenting complaint was epigastric pain (56.3%), followed by gastroesophageal reflux disease (8.3%). Most procedures were performed under local anesthesia (72.4%), predominantly with midazolam. EGD findings revealed normal esophagus in 84.6% of patients, while 38.6% had incompetent cardia without hiatus hernia and 26.2% with hiatus hernia. Hyperemic gastric mucosa was the most common stomach finding (57.1%), while 83.7% of patients had hyperemic antral mucosa. Duodenal evaluation showed normal first part of duodenum (D1) in 85.4% and normal second part of duodenum (D2) in 96.9% of patients. The most frequent overall diagnostic conclusion was diffuse gastritis (29.4%), while mass lesions were identified in 2.3% of cases.ConclusionEGD in the Gaza Strip revealed a high prevalence of gastritis and reflux-related disorders, with a smaller but clinically significant proportion of structural abnormalities and mass lesions. Epigastric pain was the leading indication for the procedure. These findings highlight the continued importance of EGD as a diagnostic tool in resource-constrained healthcare systems and emphasize the need for preventive measures, particularly for gastritis and reflux disease. Further prospective studies are recommended to evaluate risk factors, treatment adherence, and long-term outcomes. Introduction Acute UGIB is a frequent medical emergency that gastroenterologists often handle, and UGIB is a leading cause of death and disability worldwide [1, 2]. Depending on where you are in Sub-Saharan Africa, the mortality toll may be as high as 30%, with an annual incidence rate of 6–10% [3–5]. UGIB is more common in males and the elderly, and it occurs four times more often than lower GI bleed [3, 6, 7]. Variceal and nonvariceal UGIB are often used terms due to differences in treatment approaches and outcomes [8]. Nearly half of all instances of UGIB are caused by peptic ulcer disease (PUD), with esophageal varices coming in second [9, 10]. But studies in Sub-Saharan Africa have shown that esophageal varices are the leading cause [4–11]. Additional significant reasons for UGIB include gastritis, esophagitis, duodenitis, Mallory-Weiss tears, and malignancies of the upper gastrointestinal tract [12]. For effective patient management, determining the cause of UGIB is essential. For patients with UGIB, the gold standard for examination is upper GI endoscopy. Both diagnostic and therapeutic applications may be possible with it [13]. There has been less research on UGIB in Nigeria; what little there is shows that the leading cause varies significantly across the country’s northern and southern regions [14, 15]. There is a need to reevaluate the causes of UGIB in order to update current knowledge for proper UGIB treatment in our setting, as previous study that established the etiology of UGIB in Zaria happened approximately thirty years ago [16]. The esophagus and the Treitz ligament are the sites of genesis for upper gastrointestinal hemorrhage [17]. With a 10% mortality rate [18, 19], it is among the most prevalent gastrointestinal crises. The mortality rate has been the same over the last 50 years [18–20], despite advances in UGIB diagnosis and treatment. Patients should be divided into low-risk and high-risk categories using a risk-stratification tool. This will help with treatment and follow-up [19]. Multiple studies have shown many variables that increase the likelihood of dying. Additionally, a variety of risk ratings have been developed. Since its introduction in 1996, the Rockall score has been the de facto standard for evaluating risk. This score calculates the risk of death after UGIB by combining the patient’s age, systolic blood pressure, heart rate, extra medical conditions, and endoscopic findings [19]. Among the many widely used scoring systems is the Glasgow Blatchford Score [19]. Regular or inappropriate use of certain painkillers—particularly non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, diclofenac, and aspirin—can negatively affect the gastric mucosa. These medications inhibit prostaglandin synthesis, which normally helps protect the stomach lining by promoting mucus and bicarbonate production and maintaining adequate blood flow. When prostaglandins are reduced, the mucosa becomes more vulnerable to irritation and damage from stomach acid, increasing the risk of gastritis, erosions, and even peptic ulcer formation. The risk is further heightened with high doses, prolonged use, taking NSAIDs on an empty stomach, or combining them with other gastric irritants like corticosteroids or alcohol [14–16]. One of the leading causes of death and disability is upper gastrointestinal bleeding. By way of illustration, one retrospective study comprised 130 inpatients with UGIB during a two-year period [21]. Another study also discovered UGIB in 18.7% of patients who underwent fiberoptic upper GI endoscopy [22]. The two studies found that esophageal varices and PUD were the leading causes. Research shows that patients hospitalized with UGIB have a mortality rate of 10% to 17% [21–23]. Patients having esophagogastroduodenoscopy (EGD) at Gaza Hospitals were the focus of this study, which sought to shed light on their clinical features. Methods Study design This research employed a retrospective analytical study design, incorporating both descriptive and correlational components. The retrospective nature of the study was chosen because it allows for the analysis of existing medical records to identify patterns and associations without influencing patient care or outcomes. A descriptive approach was necessary to outline the demographic and clinical characteristics of patients who underwent EGD, while the correlational component facilitated the exploration of potential relationships between patients’ presenting complaints, EGD findings, and underlying causes of upper gastrointestinal bleeding (UGIB). Given that the primary objective of the study was to assess the clinical indications, presenting features, and outcomes of EGD among patients at the Gaza Strip Hospitals, this design was deemed the most appropriate and methodologically sound. Study setting The study was carried out at the endoscopy unit of the Gaza Strip Hospitals, which is one of the leading tertiary care facilities in the southern Gaza Strip and provides specialized diagnostic and therapeutic services to a large catchment population. The hospital’s endoscopy unit is equipped with modern diagnostic tools and receives referrals from different parts of the region, making it an appropriate and representative setting for the study. Data collection was conducted over a month period, but included all patients who had undergone EGD during the period 2017–2022. Participants and sampling The study population consisted of all patients who underwent EGD at the Gaza Strip Hospitals during the period 2017–2022. A comprehensive sampling strategy was applied, whereby all eligible patients within the study timeframe were included to maximize representativeness and reduce sampling bias. Patients were identified through the hospital’s medical records system, and data were extracted accordingly. To maintain the study’s focus on EGD -related outcomes, specific exclusion criteria were applied: Patients who underwent combined double-scope procedures (gastroscopy and colonoscopy simultaneously).Patients who underwent colonoscopy alone without EGD.Patients who had undergone EGD in years prior to 2022.Younger patients less than 20 years of age. Patients who underwent combined double-scope procedures (gastroscopy and colonoscopy simultaneously). Patients who underwent combined double-scope procedures (gastroscopy and colonoscopy simultaneously). Patients who underwent colonoscopy alone without EGD. Patients who underwent colonoscopy alone without EGD. Patients who had undergone EGD in years prior to 2022. Patients who had undergone EGD in years prior to 2022. Younger patients less than 20 years of age. Younger patients less than 20 years of age. Data collection Data were retrieved retrospectively from patients’ medical records and entered into a structured questionnaire developed by the researchers. The questionnaire was designed based on a thorough review of the most recent literature to ensure that all relevant clinical and demographic variables were captured. The data collection tool included sections covering sociodemographic details (such as age, sex, and residency), patients’ presenting complaints, medical history, laboratory investigations, and endoscopic findings. The retrospective collection of data ensured that no patient’s care or management was influenced by the study procedures. Study instrument The primary study instrument was a self-designed structured questionnaire. The tool was developed in alignment with current evidence-based studies and validated instruments reported in recent published literature. It was divided into three main domains: (1) baseline sociodemographic and clinical information, (2) findings and observations documented during the EGD procedure, and (3) relevant laboratory investigations performed prior to or following the procedure. The questionnaire was designed to ensure completeness of information while maintaining clarity and ease of data extraction. Definition of findings A normal mucosa was defined endoscopically as having a smooth, glistening surface with uniform color and vascular pattern, and no evidence of erythema, hyperemia, edema, erosions, ulcerations, nodularity, or visible lesions. In the esophagus, normal mucosa appeared pale and smooth with an intact squamocolumnar junction and no signs of inflammation or erosive changes. In the stomach, normal mucosa was characterized by its pink, glossy appearance with clearly visible rugal folds and an undisturbed vascular pattern. In the duodenum, normal mucosa displayed a velvety, golden appearance with intact villi and no signs of atrophy, scalloping, or inflammatory changes. Statistical analysis All data extracted from the questionnaires were coded and entered into the Statistical Package for the Social Sciences (SPSS), version 23. Descriptive statistics, including frequencies, percentages, means, medians, and standard deviations, were used to summarize the patients’ demographic and clinical characteristics. Ethical considerations Prior to data collection, formal ethical approval was obtained from the Health Research Committee of the Ministry of Health (MoH) in the Gaza Strip. Permission was granted to access patients’ medical records solely for research purposes. The confidentiality and privacy of all patient information were strictly maintained throughout the study. No identifying patient information was recorded or disclosed, and all data were handled in accordance with ethical principles for medical research and the standards of the Declaration of Helsinki. Results The study included 1088 patients who were undergone EGD and were admitted from outpatient department, internal departments or referred from other hospital. The mean age of study participants was 42.57 ± 16.76 years with median age of 40 years. The patients’ age ranged from 21 to 92 years. Age groups distribution is presented in Fig. 1. As shown, the peak age group is at middle-aged population. The male to female ratio was close; the study included 550 males (50.6%) and 538 females (49.4%). The route of admission is presented in Fig. 2. Most of participants had been admitted through outpatient department schedule (n = 1004, 92.3%). Fig. 1Age groups distribution among study participants Age groups distribution among study participants Fig. 2Admission route distribution among study participants Admission route distribution among study participants The number of patients varied between years and months. The highest year was in 2017 with 219 cases and lowest during 2022 with 118. Figure 3 shows this distribution. Fig. 3Distribution of cases during study period Distribution of cases during study period The presenting symptom or indication that led to the decision for EGD varied among study participants. The most common symptom was epigastric pain (n = 613, 56.3%) followed by gastroesophageal reflux disease (GERD) (n = 90, 8.3%). Figure 4 shows the frequency of presenting complaint or indication among study participants. Other symptoms included postprandial disorder, heart burn, stoke for percutaneous endoscopic gastrostomy insertion (PEG) and chest pain. Fig. 4Indication for performing EGD among study participants Indication for performing EGD among study participants The anesthetic method used for the procedure was either local (n = 788, 72.4%) or general anesthesia (n = 300, 27.6%). Other local agents used were propofol and ezracain. Findings of EGD procedure was divided according to the examined part. Table 1 shows the findings of EGD of esophagus and cardia of stomach. However, normal esophagus findings were reported among 920 participants (84.6%) while competent cardia was found among 369 participants (33.9%). Table 1EGD findings of esophagus and stomach cardia among study participantsEsophagus(n, %)Stomach cardia(n, %)Normal (920, 84.6%)Competent (369, 33.9%)Hyperemic mucosa (58, 5.3%)Incompetent without hiatus hernia (420, 38.6%)Mucosal erosion (35, 3.2%)Incompetent with hiatus hernia (285, 26.2%)White patches (candidiasis) (16, 1.5%)Others (14, 1.3%)Stenosis (10, 0.9%)More than one of previous findings (33, 3%)Others (16, 1.5%) Table 1EGD findings of esophagus and stomach cardia among study participantsEsophagus(n, %)Stomach cardia(n, %)Normal (920, 84.6%)Competent (369, 33.9%)Hyperemic mucosa (58, 5.3%)Incompetent without hiatus hernia (420, 38.6%)Mucosal erosion (35, 3.2%)Incompetent with hiatus hernia (285, 26.2%)White patches (candidiasis) (16, 1.5%)Others (14, 1.3%)Stenosis (10, 0.9%)More than one of previous findings (33, 3%)Others (16, 1.5%) EGD findings of esophagus and stomach cardia among study participants Table 2 shows the findings of EGD procedure of stomach and stomach antrum. Nevertheless, normal stomach findings were reported among third of participants (n = 356, 32.7%) while normal antral findings was found among 124 participants (11.4%). Table 2EGD findings of stomach among study participantsStomach(n, %)Stomach antrum(n, %)Normal (356, 32.7%)Normal (124, 11.4%)Hyperemic mucosa (621, 57.1%)Hyperemic mucosa (911, 83.7%)Mass (13, 1.2%)More than one of previous findings (35, 3.2%)More than one of previous findings (58, 5.3%)Others (19, 1.8%)Others (39, 3.6%) Table 2EGD findings of stomach among study participantsStomach(n, %)Stomach antrum(n, %)Normal (356, 32.7%)Normal (124, 11.4%)Hyperemic mucosa (621, 57.1%)Hyperemic mucosa (911, 83.7%)Mass (13, 1.2%)More than one of previous findings (35, 3.2%)More than one of previous findings (58, 5.3%)Others (19, 1.8%)Others (39, 3.6%) EGD findings of stomach among study participants Table 3 shows the findings of EGD procedure of duodenal parts (D1 and D2). Nevertheless, normal duodenal findings were reported among 929 (85.4%) and 1054 (96.9%) participants for D1 and D2 respectively. Table 3EGD findings of duodenal parts among study participantsFindingD1(n, %)D2(n, %)Normal929, 85.4%1054, 96.9%Hyperemic mucosa104, 9.6%9, 0.8%Ulcer13, 1.2%1, 0.1%Others19, 1.8%19, 1.8% Table 3EGD findings of duodenal parts among study participantsFindingD1(n, %)D2(n, %)Normal929, 85.4%1054, 96.9%Hyperemic mucosa104, 9.6%9, 0.8%Ulcer13, 1.2%1, 0.1%Others19, 1.8%19, 1.8% EGD findings of duodenal parts among study participants The procedure conclusion findings was diffuse normal study among 49 participants (4.5%). Diffuse gastritis was found among 320 participants (29.4%) other conclusions were antral gastritis, sliding hiatus hernia, reflux esophagitis and mass. Mass finding was reported among 25 participants (2.3%). Physician, performing the procedure, recommendations varied according to each case. However, there were common frequent recommendations by the physician such as proton pump inhibitors use (n = 293, 27%), helicobacter pylori eradication treatment (n = 196, 18%), further testing (n = 30, 2.8%), surgical treatment (n = 11, 1%) or a combination between these recommendations (n = 486, 44.7%). Discussion Dyspepsia and other gastrointestinal diseases are common and need medical attention all over the globe [1–5]. Data derived from preliminary and clinical experiments conducted in scholar or expert settings are the foundation of dyspepsia rules, since there is a lack of exploratory evidence on the topic. It may have significant implications for standard procedures that are essential to disprove the execution interaction [6]. Short esophagogastroduodenoscopy (EGD) should be performed on all patients with dyspepsia who are 45 or 55 years old, or who have side effects, according to current regulations [7]. There are a number of factors, including the specialist-patient connection and the patient’s consistency to the specialist’s recommendations, that are associated with the successful implementation of recommendations that remember intrusive evaluation for frequent important consideration practice [8, 9]. For example, it has not been shown that variables such as family history, perceived risk, self-sufficiency, illness knowledge, or the use of educational recorded material influence patients’ decision about colorectal cancer (CRC) screening using a Fecal Occult Blood Test (FOBT) [8]. However, research has shown that critical consideration patients are more likely to adhere to colonoscopy and FOBT protocols when they receive personalized empowerment booklets [9, 10]. Knowing all the factors that could affect a patient’s dynamic cycle is crucial for understanding them and helping them change their viewpoint in order to achieve greater consistency rates. At the moment, there is an emphasis on calm, focused communication and shared dynamics, which seem to cause a critical expansion in tolerant information, work on individual and patient satisfaction with regard to clinical consideration, and furthermore reduce anxiety and decisional struggle [10, 11]. Over the last several decades, researchers have poured resources into studying human dynamic interaction in depth, with the goal of developing models that might explain why patients consistently follow doctors’ orders [11–13]. The Theory of Planned Behavior (TPB) is one of the concepts put out in an effort to comprehend and influence human behavior [14]. Two studies assessed the esophageal and gastric-related adverse effects in a critically ill population. Those patients who tested positive for esophageal or gastric-related complications during their visits to selected national practices were sent for upper endoscopy. Endoscopically, a hyperemic gastric mucosa appears reddened, inflamed, and sometimes edematous, reflecting increased vascularity and superficial irritation. This visual picture typically correlates with histological findings of acute or chronic gastritis, where microscopic examination may reveal mucosal congestion, epithelial damage, and infiltration by inflammatory cells such as neutrophils or lymphocytes. Hyperemia on endoscopy is therefore an important indicator of underlying mucosal inflammation, even when structural lesions like ulcers or erosions are not present. Studies in gastroenterology consistently show that erythematous or hyperemic mucosa corresponds strongly with histologic evidence of gastritis, as described in standard references such as Sleisenger & Fordtran’s Gastrointestinal and Liver Disease, Sydney System for Gastritis Classification, and research documenting endoscopic–histologic correlations in inflammatory gastric disease. Patients undergoing UGIE at the endoscopy unit of Gaza Strip Hospitals were anticipated to have their segment quality, signs, and endoscopic findings reported in this research. This research delves into the first account of UGIE symptoms. The majority of our members had dyspepsia as their primary indication for upper gastrointestinal endoscopy [12, 14–17]. Repetitive heaving, esophageal varices in cirrhotic patients, and side effects of UGI dying were the different reasons why our patients had UGIE. Similarly to the 1.0% documented by the focus group, only 1.1% of our patients with dysphagia underwent upper gastrointestinal endoscopy [12]. This goes against the findings of a Malawian study that identified dysphagia as the hallmark of UGIE [18]. Dysphagia was a symptom of UGIE in 37% of their patients. Malawi may stand out due to its high incidence of esophageal malignant development [19]. Furthermore, endoscopic procedures are limited in Malawi, thus only patients who are very cautious are considered for upper GI endoscopy [18]. Among our patients, gastritis and duodenitis were the most common endoscopic findings in that order. This is consistent with previous research [3, 10] that described gastritis and duodenitis as common endoscopic findings in their patient population. In Kumasi, gastric ulcers were more often studied than duodenal ulcers [12]. In contrast, one Accra study found that stomach ulcers were less common than duodenal ulcers [3]. According to research, gastric holes were more common than duodenal holes among the people of Kumasi [20]. Patients who had gastric sleeve procedures were also more likely to be repeat users and abusers of nonsteroidal anti-inflammatory drugs (NSAIDS) and alternative medicine [20]. Compared to previous studies conducted in this country, the number of esophageal varices identified in this research was higher [12]. This is because endoscopy is recommended for individuals with liver cirrhosis who do not have drainage, according to this research. Results were much lower than those of previous studies conducted in this country [3, 12]. Possible explanations for the difference include improved endoscopic procedures for identifying UGI pathology, more refined methods of clinical diagnosis over the past decade, or the relative scarcity of endoscopy services, which leads to appropriate referrals for the procedure. Data about the potential impact of Proton Pump Inhibitor (PPI) and NSAID use on endoscopic findings was not available in all trials. The colonization of the stomach by Helicobacter pylori is perhaps the most well-known illness in the world. Some researchers have presented it as the most well-known persistent bacterial contamination in humans [21, 22]. It is the principal etiological expert of gastric cancer and peptic ulcer disease and the basic driver of chronic gastritis. A healthier lifestyle and improved antimicrobial omens have contributed to a decline in the prevalence of Helicobacter pylori in several countries. In this investigation, Helicobacter pylori was found to be 44.9% of the time. This is about the same as the 45.2% reported [13], but in the nation it’s 74.8% [23]. Additional previous studies in agricultural countries [24], as well as Ghana [25] and Nigeria [26], have also shown a high prevalence of H. pylori. Possible causes for this difference include the increasing use of anti-microbial combination and proton pump inhibitors (PPI) for the treatment of the condition, as well as their widespread and unpredictable use. Participants who were already using or had recently used anti-infective drugs or proton pump inhibitors were not excluded from the trial. It could also be associated with more advanced sterilisation practices among the residents [27]. The continued prevalence of 45.2% is still high compared to rates in developed countries [28], even if the prevalence of H. pylori among patients has decreased in our study. H. Pylori infection is more common in areas with lower socioeconomic status, less access to sterilisation and basic sanitation services, and poor dietary habits; however, factors such as geography, nationality, orientation, and maturity also play a role in the spread of the infection [29, 30]. The higher prevalence of H. Pylori in countries with a strong agricultural sector may be explicable by this. H. pylori infection was detected in 48.3% of the 89 participants, with notable variations between diagnostic tests. The results showed a significant association between H. pylori infection and the type of drinking water consumed during childhood, while no significant correlations were found with age, sex, marital status, smoking, socioeconomic indicators, or other lifestyle factors. Tea consumption appeared to have a protective effect against infection. These findings highlight key environmental influences—particularly childhood water sources—on H. pylori occurrence in the Gaza Strip [31]. Conclusion The commonest indication for UGIE in the studied patients was epigastric pain and most of these patients had diffuse gastritis on conclusion findings. Only few patients had normal findings. Gastric ulcers were commoner than duodenal ulcers among study participants. The outcomes of this study have implications for policy and planning. There is a need to identify the common causes of gastritis in the community. This will help formulate and put in place community-based interventions including education to avoid these precipitating factors. Patients with dyspepsia with no warning symptoms should undergo EGD, particularly males, patients with body mass index > 25 and patients with epigastric pain. EGD has significant implications in patients, especially for those with independent risk factors. Therefore, EGD should not be performed based on warning symptoms exclusively.